Guardian Pharmacy Services Inc. (GRDN) Insider Trading
Insiders bought $100k and sold $280M on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director Thomas J Salentine Jr sold $106M on Mar 20, 44% of their stake, outside a plan.
Get an email when GRDN's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Mar 20 | David K Morris See Remarks | SoldNo plan | 187,855 | $29.68 | $5.58M | 42% | Form 4 |
| Mar 20 | Pharmacy Investors, LLC Large holder | SoldNo plan | 827,636 | $29.68 | $24.6M | 44% | Form 4 |
| Mar 20 | Fred Burke See Remarks | SoldNo plan | 671,432 | $29.68 | $19.9M | 44% | Form 4 |
| Mar 20 | Thomas J Salentine Jr Director | SoldNo plan | 3,570,677 | $29.68 | $106M | 44% | Form 4 |
| Mar 20 | Bindley Capital Partners I, LLC Large holder | SoldNo plan | 3,570,677 | $29.68 | $106M | 44% | Form 4 |
| Mar 20 | John Ackerman Director | SoldNo plan 2 parts | 1,103,364 | $29.68 average | $32.7M | 44% | Form 4 |
| Mar 20 | William E Bindley Director | SoldNo plan | 3,570,677 | $29.68 | $106M | 44% | Form 4 |
| Mar 20 | Kendall Forbes See Remarks | SoldNo plan | 346,672 | $29.68 | $10.3M | 43% | Form 4 |
| Mar 20 | Cardinal Equity Fund, L.p. Large holder | SoldNo plan | 275,728 | $29.68 | $8.18M | 44% | Form 4 |
| Dec 3, 2025 | Steven D Cosler Director | Bought | 3,370 | $29.61 | $100k | 16% | Form 4 |
| May 27, 2025 – May 28, 2025 | Cardinal Equity Fund, L.p. Large holder | SoldNo plan 2 parts | 321,263 | $20.16 average | $6.48M | 34% | Form 4 |
| May 27, 2025 – May 28, 2025 | Pharmacy Investors, LLC Large holder | SoldNo plan 2 parts | 964,316 | $20.16 average | $19.4M | 34% | Form 4 |
| May 27, 2025 – May 28, 2025 | William E Bindley Director | SoldNo plan 2 parts | 4,160,359 | $20.16 average | $83.9M | 68% | Form 4 |
| May 27, 2025 – May 28, 2025 | Thomas J Salentine Jr Director | SoldNo plan 2 parts | 4,160,359 | $20.16 average | $83.9M | 68% | Form 4 |
| May 27, 2025 – May 28, 2025 | John Ackerman Director | SoldNo plan 4 parts | 1,285,579 | $20.16 average | $25.9M | 68% | Form 4 |
| May 27, 2025 – May 28, 2025 | David K Morris See Remarks | SoldNo plan 2 parts | 437,759 | $20.16 average | $8.83M | 67% | Form 4 |
| May 27, 2025 – May 28, 2025 | Fred Burke See Remarks | SoldNo plan 2 parts | 885,807 | $20.16 average | $17.9M | 68% | Form 4 |
| May 27, 2025 – May 28, 2025 | Kendall Forbes See Remarks | SoldNo plan 2 parts | 415,049 | $20.16 average | $8.37M | 67% | Form 4 |
| May 27, 2025 – May 28, 2025 | Bindley Capital Partners I, LLC Large holder | SoldNo plan 2 parts | 4,160,359 | $20.16 average | $83.9M | 68% | Form 4 |
| Nov 19, 2024 | Steven D Cosler Director | Bought | 7,000 | $21.22 | $149k | 65% | Form 4 |
- Mar 20No planDavid K MorrisSee Remarks · sold 187,855 at $29.68$5.58M42% of stake
- Mar 20No planPharmacy Investors, LLCLarge holder · sold 827,636 at $29.68$24.6M44% of stake
- Mar 20No planFred BurkeSee Remarks · sold 671,432 at $29.68$19.9M44% of stake
- Mar 20No planThomas J Salentine JrDirector · sold 3,570,677 at $29.68$106M44% of stake
- Mar 20No planBindley Capital Partners I, LLCLarge holder · sold 3,570,677 at $29.68$106M44% of stake
- Mar 20No planJohn AckermanDirector · sold 1,103,364 at avg $29.68$32.7M44% of stake
- Mar 20No planWilliam E BindleyDirector · sold 3,570,677 at $29.68$106M44% of stake
- Mar 20No planKendall ForbesSee Remarks · sold 346,672 at $29.68$10.3M43% of stake
- Mar 20No planCardinal Equity Fund, L.p.Large holder · sold 275,728 at $29.68$8.18M44% of stake
- Dec 3, 2025Steven D CoslerDirector · bought 3,370 at $29.61$100k16% of stake
- May 27, 2025 – May 28, 2025No planCardinal Equity Fund, L.p.Large holder · sold 321,263 at avg $20.16$6.48M34% of stake
- May 27, 2025 – May 28, 2025No planPharmacy Investors, LLCLarge holder · sold 964,316 at avg $20.16$19.4M34% of stake
- May 27, 2025 – May 28, 2025No planWilliam E BindleyDirector · sold 4,160,359 at avg $20.16$83.9M68% of stake
- May 27, 2025 – May 28, 2025No planThomas J Salentine JrDirector · sold 4,160,359 at avg $20.16$83.9M68% of stake
- May 27, 2025 – May 28, 2025No planJohn AckermanDirector · sold 1,285,579 at avg $20.16$25.9M68% of stake
- May 27, 2025 – May 28, 2025No planDavid K MorrisSee Remarks · sold 437,759 at avg $20.16$8.83M67% of stake
- May 27, 2025 – May 28, 2025No planFred BurkeSee Remarks · sold 885,807 at avg $20.16$17.9M68% of stake
- May 27, 2025 – May 28, 2025No planKendall ForbesSee Remarks · sold 415,049 at avg $20.16$8.37M67% of stake
- May 27, 2025 – May 28, 2025No planBindley Capital Partners I, LLCLarge holder · sold 4,160,359 at avg $20.16$83.9M68% of stake
- Nov 19, 2024Steven D CoslerDirector · bought 7,000 at $21.22$149k65% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Retail-Drug Stores and Proprietary Stores
Spot a number that looks wrong? Check it in GRDN's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing GRDN
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.